Epilogue On Esperion Therapeutics Stock (NASDAQ:ESPR)
· seekingalpha.com
Esperion Therapeutics is being acquired by ARCHIMED, with shareholders receiving CVRs tied to future milestone payments. See why ESPR stock is downgraded to hold.
The story for Esperion Therapeutics ( ESPR ) as a publicly traded company came to an end on May 1st with an acquisition offer by healthcare investment firm ARCH...